SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-002498
Filing Date
2021-03-08
Accepted
2021-03-08 08:01:28
Documents
16
Period of Report
2021-03-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ardx-20210308x8k.htm   iXBRL 8-K 34588
2 EX-99.1 ardx-20210308xex99d1.htm EX-99.1 134813
3 GRAPHIC ardx-20210308xex99d1001.jpg GRAPHIC 2381
4 GRAPHIC ardx-20210308x8k001.jpg GRAPHIC 2570
  Complete submission text file 0001558370-21-002498.txt   344730

Data Files

Seq Description Document Type Size
5 EX-101.SCH ardx-20210308.xsd EX-101.SCH 3253
6 EX-101.DEF ardx-20210308_def.xml EX-101.DEF 13330
7 EX-101.LAB ardx-20210308_lab.xml EX-101.LAB 19783
8 EX-101.PRE ardx-20210308_pre.xml EX-101.PRE 13676
9 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20210308x8k_htm.xml XML 6449
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36485 | Film No.: 21720656
SIC: 2834 Pharmaceutical Preparations